670 SWITCHING FROM LEUPROLIDE TO DEGARELIX VS CONTINUOUS DEGARELIX TREATMENT – EFFECTS ON LONG-TERM PROSTATE-SPECIFIC ANTIGEN CONTROL

Authors :: Tine Kold Olesen
Bo-Eric Persson
Judd W. Moul
Neal D. Shore
E. David Crawford
Source :: Journal of Urology. 183
Publication Year :: 2010
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2010.

Subjects :: Prostate-specific antigen
chemistry.chemical_compound
medicine.medical_specialty
chemistry
business.industry
Urology
Medicine
Degarelix
business
Term (time)

Full Text Access

Tools